This comprehensive approach, similar to previously reported approaches [40], enabled us to reliably and reproducibly detect VEGFR2 immunoreactivity in stromal blood vessels in the vast majority of NSCLC cases analyzed (Table 2, Fig. 7A). The gene discussed is KDR; the disease is non-small cell lung carcinoma.